H.R.4596 - National Cancer Act of 2002107th Congress (2001-2002)
|Sponsor:||Rep. Capps, Lois [D-CA-22] (Introduced 04/25/2002)|
|Committees:||House - Energy and Commerce; Education and the Workforce; Ways and Means|
|Latest Action:||House - 07/15/2002 Referred to the Subcommittee on Employer-Employee Relations. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Summary: H.R.4596 — 107th Congress (2001-2002)All Information (Except Text)
National Cancer Act of 2002 - Provides a comprehensive Federal effort relating to treatments for and the prevention of cancer.
Introduced in House (04/25/2002)
Amends the Public Health Service Act to fund prevention and treatment programs of the National Cancer Institute, including translational cancer research (research needed to transform scientific discoveries into approaches and products to treat and cure cancer).
Addresses issues of cancer care, including: (1) clinical trial participation; (2) workforce needs; (3) Medicare coverage; (4) protocols and guidelines; (5) National Program of Comprehensive Cancer Control Plans; (5) the supply of researchers; (6) environmental risk factors research; and (7) a colorectal cancer screening demonstration program.
Requires health insurance plans covered by the Public Health Service Act and the Employee Retirement Income Security Act of 1974 to provide: (1) coverage for clinical trials; (2) coverage of cancer screening, including tobacco and nutrition counseling and genetic testing; and (3) patient access to benefit information.
Addresses issues of managing physicians and quality of care for cancer patients covered by such plans, including designating a lead managing physician.
Amends the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to regulate tobacco products. Sets forth requirements pertaining to: (1) adulteration; (2) misbranding; (3) the submission of health information; (4) annual registration and biennial inspection of processors; (5) biannual reporting of product list changes; (6) good manufacturing practices; (7) product performance standards; (8) information, notification, and other remedies; (9) records and reports; (10) premarket review; (11) judicial review; (12) postmarket surveillance; (13) reduced risk tobacco products; (14) preservation of State and local authority; and (15) equal treatment of retail outlets.
Amends the Federal Cigarette Labeling and Advertising Act to: (1) revise cigarette labeling, advertising, and marketing requirements; and (2) authorize the Secretary to require disclosure of tar, nicotine, and other smoke constituents on package labels and/or advertisements.
Amends the Comprehensive Smokeless Tobacco Health Education Act of 1986 to revise smokeless tobacco warning label and advertising requirements.